Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Lee’s Pharmaceutical Holdings Limited ( (HK:0950) ) has shared an announcement.
Lee’s Pharmaceutical Holdings Limited announced a final cash dividend of HKD 0.025 per share for the financial year ending December 31, 2024. The dividend reflects the company’s financial performance and commitment to providing returns to its shareholders, with the payment date set for June 16, 2025.
More about Lee’s Pharmaceutical Holdings Limited
Lee’s Pharmaceutical Holdings Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and sales of pharmaceutical products. The company primarily targets the healthcare market with a range of therapeutic products.
Average Trading Volume: 285,012
Technical Sentiment Signal: Sell
Current Market Cap: HK$836.1M
For an in-depth examination of 0950 stock, go to TipRanks’ Stock Analysis page.